Cgref1-/-mice showed lower tendencies of developing obesity, hyperglycaemia and dyslipidaemia, associated with compromised hepatic de novo lipogenesis. This evidence concerns the gene CGREF1 and obesity due to melanocortin 4 receptor deficiency.